AlphaFold predicted structure
SLC16A2 · P36021

Mean pLDDT
79.6/ 100
Confident
539 residues
Confidence breakdown
- Very high(≥ 90)50%
- Confident(70–90)25%
- Low(50–70)10%
- Very low(< 50)16%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 16 member 2
Annotations refreshed 1 month ago.
Diagnostic Grade (Green)
Childhood onset dystonia, chorea or related movement disorder
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesChildhood onset hereditary spastic paraplegia
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesCongenital hypothyroidism
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesDDG2P
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesEarly onset or syndromic epilepsy
X-LINKED: hemizygous mutation in males, monoallelic mutations in females may cause disease (may be less severe, later onset than males)Fetal anomalies
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesHereditary spastic paraplegia
X-LINKED: hemizygous mutation in males, biallelic mutations in femalesHyperthyroidism
X-LINKED: hemizygous mutation in males, biallelic mutations in females+5 more panels — install the extension to see the full list inline on any page.
Allan-Herndon-Dudley syndrome
Spastic paraplegia
hereditary disease
neurodegenerative disease
Intellectual disability
Hypotonia
hereditary spastic paraplegia
Decreased activity of the pyruvate dehydrogenase complex
prostate cancer
Familial prostate cancer
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Monocarboxylate transporter 8
Specific thyroid hormone transmembrane transporter, that mediates both uptake and efflux of thyroid hormones across the cell membrane independently of pH or a Na(+) gradient. Major substrates are the iodothyronines T3 and T4 and to a lesser extent rT3 and 3,3-diiodothyronine (3,3'-T2) (PubMed:16887882, PubMed:18337592, PubMed:20628049, PubMed:23550058, PubMed:27805744, PubMed:31436139, PubMed:26426690, PubMed:38661522, PubMed:40140416, PubMed:40368961, PubMed:40680733). Acts as an important mediator of thyroid hormone transport, especially T3, through the blood-brain barrier (Probable) (PubMed:28526555). Mediates the efflux of 3,5-diiodo-L-tyrosine (DIT) and 3-iodo-L-tyrosine (MIT) (PubMed:38661522)
Curated MONDO disease pages that list SLC16A2 among their top associated genes.
SLC16A2 · P36021

Mean pLDDT
79.6/ 100
Confident
539 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0